Watson-Marlow Fluid Technology Group (WMFTG), one of the leaders in niche peristaltic pumps and associated fluid path technologies, has acquired ASEPCO through its parent company Spirax-Sarco Engineering plc, for approximately $10.5 million USD.
ASEPCO, based in California, USA, specialises in the design and manufacture of high purity aseptic valves and magnetic mixers for the bioprocessing industry.
Asepco is a natural extension of the Watson-Marlow Fluid Technology Group fluid path product portfolio and further strengthens WMFTG’s already strong global presence in the biotechnology and pharmaceutical industries. Asepco joins a product range comprising Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, BioPure single-use tubing connector systems, Alitea OEM Pumps, MasoSine Process Pumps and Bredel Hose Pumps.
Jay Whalen, President of the Watson-Marlow Fluid Technology Group comments, “The strategic acquisition of Asepco further broadens our product range and strengthens Watson-Marlow’s position in the biopharmaceutical market. This enables us to provide a more comprehensive and improved service to our customers looking for sterility throughout their fluid path. This is another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise.”